Stock Fundamentals

AI Research Report

Generate a comprehensive financial analysis report powered by AI

ANVS.US Logo

ANVS.US - Current Price

$3.23

Company Information

▼
Company Name
Annovis Bio Inc
Sector
Healthcare
Industry
Biotechnology
Exchange
NYSE
ISIN: US03615A1088
CIK: 0001477845
CUSIP: 03615A108
Currency: USD
Full Time Employees: 8
Phone: 484 875 3192
Website: https://www.annovisbio.com
Fiscal Year End: December
IPO Date: Feb 12, 2010
Description:

Annovis Bio, Inc., a clinical stage drug platform company, develops drugs to treat neurodegeneration in the United States. The company's lead product candidate is Buntanetap, which is in phase 2/3 to treat alzheimer's disease, as well as in phase 3 to treat parkinson's disease; and is in phase 2 clinical trial to treat lewy body dementia. It also develops ANVS405, which is in phase 2 and 3 clinical trials for the treatment of traumatic brain injury and/or stroke; and ANVS301, which finished phase 1 clinical trial to treat later stages of alzheimer's disease and dementia. The company was incorporated in 2008 and is headquartered in Malvern, Pennsylvania.

Address:

101 Lindenwood Drive, Malvern, PA, United States, 19355

Directors & Officers

▼
Name Title Year Born
Dr. Maria L. Maccecchini Ph.D. Founder, CEO, President & Executive Director 1951
Mr. Mark Patrick Guerin C.M.A., CPA, CFM Chief Financial Officer 1969
Dr. Cheng Fang Ph.D. Senior Vice President of Research & Development NA
Ms. Eve M. Damiano M.S., RAC Senior Vice President of Regulatory Operations NA
Ms. Melissa Gaines Senior Vice President of Clinical Operations NA
Mr. Blake Jensen M.B.A. Head of Quality NA
Ms. Hilda Maibach Senior Vice President of Statistics NA

Shares Statistics

▼
Shares Outstanding: 26.11M
Shares Float: 17.07M
% Insiders: 1,626.40%
% Institutions: 1,172.70%
Short % Float: 4.43%

Valuation Metrics

▼
Enterprise Value: $76.15M
Trailing P/E: 0.00
Forward P/E: 0.00

Financial Highlights

▼
Market Cap: $59.80M
Book Value: $0.66
Earnings/Share: $-2.10
Profit Margin: 0.00%
Operating Margin: 0.00%
ROA (TTM): -111.68%
ROE (TTM): -365.03%
Revenue (TTM): $0.00
Revenue/Share (TTM): $0.00
Earnings Growth (YOY): 0.00%
Revenue Growth (YOY): 0.00%

Stock Price History

▼

1 Year Price History

2 Years Price History

5 Years Price History

10 Years Price History

Financial Charts

▼

Revenue & Net Income

Operating Expenses

Balance Sheet Overview

Earnings Per Share (EPS)

Earnings History

▼
Date EPS Actual EPS Estimate Difference Surprise %
Dec 31, 2025 0.00 -0.31 N/A 10,000.00%
Sep 30, 2025 -0.37 -0.31 N/A -2,131.15%
Jun 30, 2025 -0.32 -0.40 N/A 2,061.52%
Mar 31, 2025 -0.32 -0.80 N/A 6,000.00%
Dec 31, 2024 -0.43 -0.20 N/A -11,500.00%
Sep 30, 2024 -0.97 -0.53 N/A -8,301.89%
Jun 30, 2024 -0.32 -0.63 N/A 4,920.63%
Mar 31, 2024 -0.72 -0.80 N/A 1,000.00%
Dec 31, 2023 -2.24 -1.30 N/A -7,230.77%
Sep 30, 2023 -1.63 -1.09 N/A -4,954.13%
Jun 30, 2023 -1.07 -1.14 N/A 614.04%
Mar 31, 2023 -1.19 -0.33 N/A -26,060.61%
Dec 31, 2022 -1.05 -1.05 N/A 0.00%
Sep 30, 2022 -0.93 -1.01 N/A 792.08%
Jun 30, 2022 -1.07 -0.64 N/A -6,718.75%
Mar 31, 2022 -0.72 -0.58 N/A -2,413.79%
Dec 31, 2021 -0.75 -0.25 N/A -20,000.00%
Sep 30, 2021 -0.35 -0.44 N/A 2,045.45%
Jun 30, 2021 -0.34 -0.37 N/A 810.81%
Mar 31, 2021 -0.46 -0.46 N/A 0.00%
Dec 31, 2020 -0.25 -0.16 N/A -5,625.00%
Sep 30, 2020 -0.15 -0.15 N/A 0.00%
Jun 30, 2020 -0.34 -0.15 N/A -12,666.67%
Mar 31, 2020 -0.10 N/A N/A N/A
Dec 31, 2019 -0.04 0.00 N/A N/A
Jun 30, 2019 -0.03 0.00 N/A N/A
Mar 31, 2019 -0.03 0.00 N/A N/A

Balance Sheet (Yearly)

▼
Date Cash Total Debt Total Assets Total Liabilities Total Equity
2024-12-31 $10.55M $N/A $13.93M $4.62M $9.31M
2023-12-31 $5.75M $N/A $10.21M $17.96M $-7.75M
2022-12-31 $28.38M $N/A $36.02M $7.70M $28.32M
2021-12-31 $45.69M $N/A $46.00M $1.51M $44.49M
2020-12-31 $8.07M $N/A $8.12M $578.38K $7.54M
2019-12-31 $1.86K $N/A $1.12M $9.69M $-8.58M
2018-12-31 $35.31K $N/A $50.99K $7.64M $-7.59M
2017-12-31 $347.47K $N/A $357.96K $7.32M $-6.97M
2012-12-31 $72.32K $N/A $2.84M $174.36K $2.66M
2011-12-31 $1.39M $N/A $21.01M $7.09M $13.93M
2010-12-31 $4.40M $N/A $22.05M $5.55M $16.49M
2009-12-31 $31.76K $N/A $1.52M $45.49K $1.48M

Insider Trading

Date Insider Name Title Transaction Type Shares Price Value
Oct 11, 2021 N/A N/A N/A N/A N/A N/A
Oct 11, 2021 N/A N/A N/A N/A N/A N/A

Watchlist

0

No stocks in watchlist